about
Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693.New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer.Ferrocene-cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel.Resistance to DNA Damaging Agents Produced Invasive Phenotype of Rat Glioma Cells-Characterization of a New in Vivo Model.Simple avarone mimetics as selective agents against multidrug resistant cancer cells.Structural differences in diarylheptanoids analogues from Alnus viridis and Alnus glutinosa influence their activity and selectivity towards cancer cells.Chemo-protective and regenerative effects of diarylheptanoids from the bark of black alder (Alnus glutinosa) in human normal keratinocytes.Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.Antioxidative activity of diarylheptanoids from the bark of black alder (Alnus glutinosa) and their interaction with anticancer drugs.Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma.Targeting autophagy to modulate cell survival: a comparative analysis in cancer, normal and embryonic cells.The T cell receptor resides in ordered plasma membrane nanodomains that aggregate upon patching of the receptorActin filaments attachment at the plasma membrane in live cells cause the formation of ordered lipid domains.Limited cholesterol depletion causes aggregation of plasma membrane lipid rafts inducing T cell activation.Clinical presentation of mild cystic fibrosis in a Serbian patient homozygous for the CFTR mutation c.1393-1G>A.MTHFR C677T polymorphism in chronic pancreatitis and pancreatic adenocarcinoma.Laurdan and di-4-ANEPPDHQ do not respond to membrane-inserted peptides and are good probes for lipid packing.Transfer of Drug Resistance Characteristics Between Cancer Cell Subpopulations: A Study Using Simple Mathematical Models.DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells.Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients' outcome.Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma.Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma.Angiotensin-converting enzyme gene insertion/deletion polymorphism in patients with chronic pancreatitis and pancreatic cancer.Diarylheptanoids from the bark of black alder inhibit the growth of sensitive and multi-drug resistant non-small cell lung carcinoma cells.[CFTR F508DEL mutation and 5T allele in patients with chronic pancreatitis and pancreatic adenocarcinoma].Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment.Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.Mutual regulation and targeting of multidrug resistance and cancer stem phenotypeModulation of Antioxidant Potential with Coenzyme Q10 Suppressed Invasion of Temozolomide-Resistant Rat Glioma andA New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-]Pyrimidine Dual Src/P-Glycoprotein InhibitorCytotoxic Activity of Royleanone Diterpenes from BenthAlkylamino and aralkylamino derivatives of avarone and its mimetic as selective agents against non-small cell lung cancer cells, their antibacterial and antifungal potentialComparative toxicity evaluation of targeted anticancer therapeutics in embryonic zebrafish and sea urchin modelsSelective Anti-Cancer Drugs against Multi-drug ResistanceNovel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer CellsParvifloron D from Plectranthus strigosus: Cytotoxicity Screening of Plectranthus spp. ExtractsPotential of Natural-Based Anticancer Compounds for P-Glycoprotein InhibitionShort-term fish oil supplementation applied in presymptomatic stage of Alzheimer's disease enhances microglial/macrophage barrier and prevents neuritic dystrophy in parietal cortex of 5xFAD mouse modelSulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistanceCKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells
P50
Q35143276-612DEE6B-EC14-4D49-A9B7-2EB51FE2268EQ38597583-992BFC20-CE84-4060-9DF5-71DCBB7FF17BQ38665011-F1C0A2FF-3D28-4DC9-9C0E-55CD9FDEDC51Q38760991-13894180-B5AE-4DCE-B9D2-08B1F0C0C896Q38774560-34EA970B-FA23-4C34-9298-62C9905B2FFEQ38788846-2468F671-5372-47E0-BAC5-FD1DF19EFF32Q38854490-54362E7B-3123-4E77-A60A-36E575AB1804Q38869271-FA670A8A-BE67-4108-9FA3-258014E54F4DQ38964619-61EF75FD-9B3F-41E9-B922-C90AB1078B33Q38975988-1AAFF3A9-4AA3-44B7-9C7E-5D5FBEB27363Q41912427-18A68F2A-55C5-4065-AF16-69DA7FE25407Q42137002-3B6AF5CC-EE96-4E7A-A53E-F2B915121894Q42518049-C4DC5861-ACC7-46B4-B043-22A6AD3DCE77Q43162864-D4AFDCCA-F045-4348-8D93-7C320F29DA57Q46382368-E0EF0CD5-5870-4389-BD3E-D18ACEE8508AQ46476769-DC43BC8F-14DC-40D2-A7B8-CC0069998C8BQ50441424-0AA6DEF2-DB80-4CC8-875B-2AEA4B7BC4D0Q50622208-1E8580A3-0FB2-48A7-92E3-168FAA4356CFQ50876153-B27F0309-E8C3-4E05-BA1C-ACA2EC8CE78FQ53474990-96152E01-8EBB-484B-A17C-40EEFA7BFF9AQ54107698-27C2BD89-76B6-4C06-9D23-CFA41D05FFF6Q54182757-919CF856-90CF-4274-B7C5-1D9BACA9F3EAQ54365845-E109D855-8FB4-44C0-B6B2-92CB146D09A0Q54513213-5822D7F7-5DE9-43DD-93F6-1375F15471CCQ54671106-F1B1BCBC-6913-4201-AB16-8D43F8CCD761Q54976871-D91867FF-2851-41D7-BACB-7BBF6ED16224Q55460969-A9CC48BC-3B79-44F0-A3E4-5F9BB9B671CEQ60644246-D8FBA44C-A903-4153-A0C0-850ED48DB191Q64104859-DF8C798E-C11A-4CAF-804D-30BBA1C53893Q67228086-4A05CAF6-3170-4A0B-B436-B76619208FC8Q67228091-003D9715-9525-4371-B7C2-4B2C8108BB38Q67228098-1F32F8CB-4AEF-467B-A53F-269929214FB9Q67228102-D4EEA493-069E-4A65-8FF6-7E023143DA25Q67228107-3E5068A1-072C-4C4A-8397-283A1DA75869Q90132867-BC894E55-907C-4806-9BCA-95A64D539B6EQ90802564-14778A54-6E52-4796-9D8C-AC325E57C921Q91068757-AFE05A89-EA0A-407C-8AAE-B1390846FFEEQ92075092-2D72A623-3552-4A4C-80BC-61448DE3A943Q92077657-FAADB387-20FC-4E57-8AFA-07C572BCFA2CQ92609469-6303FFAB-6594-4FC1-B0CF-866D0B07C0D9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jelena Dinic
@ast
Jelena Dinic
@en
Jelena Dinic
@es
Jelena Dinic
@nl
Jelena Dinic
@sl
type
label
Jelena Dinic
@ast
Jelena Dinic
@en
Jelena Dinic
@es
Jelena Dinic
@nl
Jelena Dinic
@sl
altLabel
Dragica Dinic
@en
Jelena Dinić
@en
prefLabel
Jelena Dinic
@ast
Jelena Dinic
@en
Jelena Dinic
@es
Jelena Dinic
@nl
Jelena Dinic
@sl
P106
P1153
53986060400
P21
P31
P3835
jelena-dinic
P496
0000-0003-3371-2381